Entrada Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Entrada Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q2 2024.
  • Entrada Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $76.4M, a 13.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $76.4M -$11.9M -13.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $79M +$64.7M +454% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $81.5M +$56.2M +222% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $84M +$56.6M +207% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $88.3M +$58.9M +200% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $14.2M -$17.2M -54.6% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $25.3M +$25.3M Dec 31, 2022 10-K 2024-03-13
Q3 2022 $27.4M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $29.4M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $31.4M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 Dec 31, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.